Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
677.97B
Market cap677.97B
Price-Earnings ratio
28.97
Price-Earnings ratio28.97
Dividend yield
2.10%
Dividend yield2.10%
Average volume
8.97M
Average volume8.97M
High today
$274.89
High today$274.89
Low today
$266.75
Low today$266.75
Open price
$270.17
Open price$270.17
Volume
6.67M
Volume6.67M
52 Week high
$274.89
52 Week high$274.89
52 Week low
$164.23
52 Week low$164.23

Stock Snapshot

With a market cap of 677.97B, Johnson & Johnson(JNJ) trades at $267.67. The stock has a price-to-earnings ratio of 28.97 and currently yields dividends of 2.10%.

As of 2026-07-28, Johnson & Johnson(JNJ) stock has fluctuated between $266.75 and $274.89. The current price stands at $267.67, placing the stock +0.3% above today's low and -2.6% off the high.

The Johnson & Johnson(JNJ)'s current trading volume is 6.67M, compared to an average daily volume of 8.97M.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $274.89 and a 52-week low of $164.23.

In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $274.89 and a 52-week low of $164.23.

JNJ News

CNBC 1h
Jim Cramer: J&J talc settlement is good for a stock that has so much going for it already - CNBC

...

Jim Cramer: J&J talc settlement is good for a stock that has so much going for it already - CNBC
TipRanks 5h
Johnson & Johnson: Talc Settlement Progress Removes Major Overhang; Buy Rating Reiterated with Unchanged $282 Price Target

Johnson & Johnson, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Asad Haider from Goldman Sachs maintained a Buy rati...

Benzinga 5h
Johnson & Johnson Puts 15-Year Meritless Talc Litigation To Rest

The proposed resolution, coordinated with lead plaintiff firms in federal Multi-District Litigation (MDL) and state courts, requires a 95% participation rate am...

Johnson & Johnson Puts 15-Year Meritless Talc Litigation To Rest

Analyst ratings

73%

of 26 ratings
Buy
73.1%
Hold
23.1%
Sell
3.8%

More JNJ News

TipRanks 9h
Johnson & Johnson Proposes Major Ovarian Talc Settlement

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Benzinga 10h
Stock Market Today: Dow Jones Futures Gain, Nasdaq 100 Declines as Oil Slips Ahead of Trump's Meetings With Zelensky and Netanyahu—Boeing, Coca-Cola, Johnson & Johnson in Focus

U.S. stock futures were mixed on Tuesday, as the Dow Jones index gained but the S&P 500 and Nasdaq 100 indices declined, following Monday’s mixed close. Meanwhi...

Stock Market Today: Dow Jones Futures Gain, Nasdaq 100 Declines as Oil Slips Ahead of Trump's Meetings With Zelensky and Netanyahu—Boeing, Coca-Cola, Johnson & Johnson in Focus
TipRanks 13h
J&J Strikes $5.5B Talc Settlement after Years of Lawsuits; JNJ Stock Rises

Johnson & Johnson (JNJ) shares rose 1.52% in after-hours trading on Monday after the company announced a $5.5 billion settlement to resolve tens of thousands of...

Simply Wall St 16h
Johnson And Johnson Talc Settlement Puts Colgate And Kimberly Clark Stock In Focus

Legal shockwaves from Johnson & Johnson’s proposed $5.5b talc settlement are rippling through the baby care and personal health space, reshaping how investors t...

Johnson And Johnson Talc Settlement Puts Colgate And Kimberly Clark Stock In Focus
24/7 Wall St. 19h
Why Chasing a 9% Yield Could Cost You $200,000 in Retirement Income

Why Chasing a 9% Yield Could Cost You $200,000 in Retirement Income By Michael Williams Published Jul 27, 8:25PM EDT Quick Read Generating $60,000 in retireme...

Why Chasing a 9% Yield Could Cost You $200,000 in Retirement Income
Seeking Alpha 20h
Johnson & Johnson to pay up to $5.5B to settle talc lawsuits

Johnson & Johnson (JNJ) up 1.4% post-market Monday after saying it agreed to pay up to $5.5B to settle remaining lawsuits that alleged its talc products caused...

Johnson & Johnson to pay up to $5.5B to settle talc lawsuits
TipRanks 21h
J&J announces proposed resolution of ovarian talc litigation

Johnson & Johnson announced that it has reached an agreement for a comprehensive resolution of the remaining talc litigation with the plaintiff firms leading th...

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.